izpis_h1_title_alt

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
Gobec, Stanislav (Avtor), Kos, Janko (Avtor), Mitrović, Ana (Avtor), Čemažar, Maja (Avtor), Serša, Gregor (Avtor), Sosič, Izidor (Avtor), Mirković, Bojana (Avtor), Markelc, Boštjan (Avtor), Turk, Boris (Avtor), Butinar, Miha (Avtor), Vasiljeva, Olga (Avtor)

URLURL - Predstavitvena datoteka, za dostop obiščite http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=3699&path[]=7738 Povezava se odpre v novem oknu

Izvleček
Cathepsin B is a ubiquitously expressed lysosomal cysteine protease that participates in protein turnover within lysosomes. However, its protein and activity levels have been shown to be increased in cancer. Cathepsin B endopeptidase activity is involved in the degradation of extracellular matrix,a process that promotes tumor invasion, metastasis and angiogenesis. Previously, we reported an established antibiotic nitroxoline as a potent and selective inhibitor of cathepsin B. In the present study, we elucidated its anti-tumor properties in in vitro and in vivo tumor models. Tumor and endothelial cell lines with high levels of active cathepsin B were selected for functional analysis of nitroxoline in vitro. Nitroxoline significantly reduced extracellular DQ-collagen IV degradation by all evaluated cancer cell lines using spectrofluorimetry. Nitroxoline also markedly decreased tumor cell invasion monitored in real time and reduced the invasive growth of multicellular tumor spheroids, used as a 3D in vitro model of tumor invasion. Additionally, endothelial tube formation was significantly reduced by nitroxoline in an in vitro angiogenesis assay. Finally, nitroxoline significantly abrogated tumor growth, angiogenesis and metastasis in vivo in LPB fibrosarcoma and MMTV-PyMT breast cancer mouse models. Overall, our results designate nitroxoline as a promising drug candidate for anti-cancer treatment.

Jezik:Angleški jezik
Ključne besede:katepsin B, invazivni tumor, angiogeneza, metastaze, nitroksolin
Vrsta gradiva:Delo ni kategorizirano (r6)
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Leto izida:2015
Št. strani:str. 19027-19042
Številčenje:Vol. 6, no. 22
UDK:577.2:616-006
ISSN pri članku:1949-2553
COBISS.SI-ID:3834225 Povezava se odpre v novem oknu
Število ogledov:657
Število prenosov:213
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
 
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
:
Objavi na:AddThis
AddThis uporablja piškotke, za katere potrebujemo vaše privoljenje.
Uredi privoljenje...

Gradivo je del revije

Naslov:Oncotarget
Skrajšan naslov:Oncotarget
Založnik:Impact Journals
ISSN:1949-2553
COBISS.SI-ID:3833969 Povezava se odpre v novem oknu

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj